Reference interval for type III procollagen (PIIINP) using the Advia centaur PIIINP assay in adults and elderly
The amino-terminal peptide of type III procollagen (PIIINP) is a byproduct of type III collagen synthesis that exhibits promise as a biomarker of fibrosis, specifically in monitoring hepatic fibrosis in methotrexate treated patients. The Advia Centaur ® PIIINP assay is developed for track-based auto...
Gespeichert in:
| Veröffentlicht in: | Scandinavian journal of clinical and laboratory investigation Jg. 81; H. 8; S. 649 - 652 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
England
Taylor & Francis
01.12.2021
|
| Schlagworte: | |
| ISSN: | 0036-5513, 1502-7686, 1502-7686 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | The amino-terminal peptide of type III procollagen (PIIINP) is a byproduct of type III collagen synthesis that exhibits promise as a biomarker of fibrosis, specifically in monitoring hepatic fibrosis in methotrexate treated patients. The Advia Centaur
®
PIIINP assay is developed for track-based automated laboratory systems and is suitable for large volume analysis. Reference intervals in children and younger adults have been published previously. Here we measured PIIINP to determine reference ranges, specifically including elderly patients, for whom such are currently lacking.
Samples were collected from subjects ranging from 20 to 98 years of age. Blood donors and clinical samples from primary care patients were used for reference interval calculation. Samples were analysed using the Advia Centaur
®
PIIINP assay. After exclusion of samples high in alanine transaminase (AST), aspartate transaminase (ALT), and C-reactive protein (CRP) 386 samples were used in the reference interval calculation.
We determined the following reference interval for the Advia Centaur
®
PIIINP assay: the lower limit of the reference interval (2.5% percentile with 95% CI) was 4.42 (4.20-4.65) µg/L and the upper limit of the reference interval (97.5% percentile 95% CI) 16.0 (15.04-17.02) µg/L.No significant differences in mean PIIINP concentrations were found between men and women. While differing mean PIIINP concentrations were seen among subjects in different age groups, the differences were small and partitioning of reference range was determined not to be necessary. |
|---|---|
| AbstractList | The amino-terminal peptide of type III procollagen (PIIINP) is a byproduct of type III collagen synthesis that exhibits promise as a biomarker of fibrosis, specifically in monitoring hepatic fibrosis in methotrexate treated patients. The Advia Centaur
PIIINP assay is developed for track-based automated laboratory systems and is suitable for large volume analysis. Reference intervals in children and younger adults have been published previously. Here we measured PIIINP to determine reference ranges, specifically including elderly patients, for whom such are currently lacking.
Samples were collected from subjects ranging from 20 to 98 years of age. Blood donors and clinical samples from primary care patients were used for reference interval calculation. Samples were analysed using the Advia Centaur
PIIINP assay. After exclusion of samples high in alanine transaminase (AST), aspartate transaminase (ALT), and C-reactive protein (CRP) 386 samples were used in the reference interval calculation.
We determined the following reference interval for the Advia Centaur
PIIINP assay: the lower limit of the reference interval (2.5% percentile with 95% CI) was 4.42 (4.20-4.65) µg/L and the upper limit of the reference interval (97.5% percentile 95% CI) 16.0 (15.04-17.02) µg/L.No significant differences in mean PIIINP concentrations were found between men and women. While differing mean PIIINP concentrations were seen among subjects in different age groups, the differences were small and partitioning of reference range was determined not to be necessary. The amino-terminal peptide of type III procollagen (PIIINP) is a byproduct of type III collagen synthesis that exhibits promise as a biomarker of fibrosis, specifically in monitoring hepatic fibrosis in methotrexate treated patients. The Advia Centaur® PIIINP assay is developed for track-based automated laboratory systems and is suitable for large volume analysis. Reference intervals in children and younger adults have been published previously. Here we measured PIIINP to determine reference ranges, specifically including elderly patients, for whom such are currently lacking.OBJECTIVEThe amino-terminal peptide of type III procollagen (PIIINP) is a byproduct of type III collagen synthesis that exhibits promise as a biomarker of fibrosis, specifically in monitoring hepatic fibrosis in methotrexate treated patients. The Advia Centaur® PIIINP assay is developed for track-based automated laboratory systems and is suitable for large volume analysis. Reference intervals in children and younger adults have been published previously. Here we measured PIIINP to determine reference ranges, specifically including elderly patients, for whom such are currently lacking.Samples were collected from subjects ranging from 20 to 98 years of age. Blood donors and clinical samples from primary care patients were used for reference interval calculation. Samples were analysed using the Advia Centaur® PIIINP assay. After exclusion of samples high in alanine transaminase (AST), aspartate transaminase (ALT), and C-reactive protein (CRP) 386 samples were used in the reference interval calculation.METHODSSamples were collected from subjects ranging from 20 to 98 years of age. Blood donors and clinical samples from primary care patients were used for reference interval calculation. Samples were analysed using the Advia Centaur® PIIINP assay. After exclusion of samples high in alanine transaminase (AST), aspartate transaminase (ALT), and C-reactive protein (CRP) 386 samples were used in the reference interval calculation.We determined the following reference interval for the Advia Centaur® PIIINP assay: the lower limit of the reference interval (2.5% percentile with 95% CI) was 4.42 (4.20-4.65) µg/L and the upper limit of the reference interval (97.5% percentile 95% CI) 16.0 (15.04-17.02) µg/L.No significant differences in mean PIIINP concentrations were found between men and women. While differing mean PIIINP concentrations were seen among subjects in different age groups, the differences were small and partitioning of reference range was determined not to be necessary.RESULTS AND CONCLUSIONWe determined the following reference interval for the Advia Centaur® PIIINP assay: the lower limit of the reference interval (2.5% percentile with 95% CI) was 4.42 (4.20-4.65) µg/L and the upper limit of the reference interval (97.5% percentile 95% CI) 16.0 (15.04-17.02) µg/L.No significant differences in mean PIIINP concentrations were found between men and women. While differing mean PIIINP concentrations were seen among subjects in different age groups, the differences were small and partitioning of reference range was determined not to be necessary. The amino-terminal peptide of type III procollagen (PIIINP) is a byproduct of type III collagen synthesis that exhibits promise as a biomarker of fibrosis, specifically in monitoring hepatic fibrosis in methotrexate treated patients. The Advia Centaur ® PIIINP assay is developed for track-based automated laboratory systems and is suitable for large volume analysis. Reference intervals in children and younger adults have been published previously. Here we measured PIIINP to determine reference ranges, specifically including elderly patients, for whom such are currently lacking. Samples were collected from subjects ranging from 20 to 98 years of age. Blood donors and clinical samples from primary care patients were used for reference interval calculation. Samples were analysed using the Advia Centaur ® PIIINP assay. After exclusion of samples high in alanine transaminase (AST), aspartate transaminase (ALT), and C-reactive protein (CRP) 386 samples were used in the reference interval calculation. We determined the following reference interval for the Advia Centaur ® PIIINP assay: the lower limit of the reference interval (2.5% percentile with 95% CI) was 4.42 (4.20-4.65) µg/L and the upper limit of the reference interval (97.5% percentile 95% CI) 16.0 (15.04-17.02) µg/L.No significant differences in mean PIIINP concentrations were found between men and women. While differing mean PIIINP concentrations were seen among subjects in different age groups, the differences were small and partitioning of reference range was determined not to be necessary. OBJECTIVE: The amino-terminal peptide of type III procollagen (PIIINP) is a byproduct of type III collagen synthesis that exhibits promise as a biomarker of fibrosis, specifically in monitoring hepatic fibrosis in methotrexate treated patients. The Advia Centaur ® PIIINP assay is developed for track-based automated laboratory systems and is suitable for large volume analysis. Reference intervals in children and younger adults have been published previously. Here we measured PIIINP to determine reference ranges, specifically including elderly patients, for whom such are currently lacking. METHODS: Samples were collected from subjects ranging from 20 to 98 years of age. Blood donors and clinical samples from primary care patients were used for reference interval calculation. Samples were analysed using the Advia Centaur ® PIIINP assay. After exclusion of samples high in alanine transaminase (AST), aspartate transaminase (ALT), and C-reactive protein (CRP) 386 samples were used in the reference interval calculation. RESULTS AND CONCLUSION: We determined the following reference interval for the Advia Centaur ® PIIINP assay: the lower limit of the reference interval (2.5% percentile with 95% CI) was 4.42 (4.20-4.65) µg/L and the upper limit of the reference interval (97.5% percentile 95% CI) 16.0 (15.04-17.02) µg/L.No significant differences in mean PIIINP concentrations were found between men and women. While differing mean PIIINP concentrations were seen among subjects in different age groups, the differences were small and partitioning of reference range was determined not to be necessary. |
| Author | Pettersson-Pablo, Paul Samyn, Dieter Wasim, Jamil Vink, Martin |
| Author_xml | – sequence: 1 givenname: Paul orcidid: 0000-0001-8458-6448 surname: Pettersson-Pablo fullname: Pettersson-Pablo, Paul organization: School of Medicine, Faculty of Medicine, Örebro University – sequence: 2 givenname: Dieter orcidid: 0000-0002-0381-251X surname: Samyn fullname: Samyn, Dieter organization: School of Medicine, Faculty of Medicine, Örebro University – sequence: 3 givenname: Jamil surname: Wasim fullname: Wasim, Jamil organization: Faculty of Medicine, Section of Medical Sciences, Örebro University – sequence: 4 givenname: Martin orcidid: 0000-0002-4256-6008 surname: Vink fullname: Vink, Martin organization: School of Medicine, Faculty of Medicine, Örebro University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34779323$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-95445$$DView record from Swedish Publication Index (Örebro universitet) |
| BookMark | eNqFkV9vFCEUxYmpsdvqR9DwWBOnMvyZmY0vbqrWTRptjPpKGLizYljYAtNmvr1sZrcPPugDl3D5nUMu5wyd-OABoZc1uaxJR94SwhohanZJCa1LITXh4gla1ILQqm265gQt9ky1h07RWUq_STmzjj9Dp4y37ZJRtkDhGwwQwWvA1meI98rhIUScpx3g9XqNdzHo4JzagMcXt6Xz5fY1HpP1G5x_AV6Ze6uwBp_VGPF8j1VKaip-WJnR5YSVNxicgeim5-jpoFyCF4f9HP349PH71efq5uv1-mp1U2kuSK4AGB26tu37pSDaGK0FbURPe6U5b2puGGgwwLqBMT4MPVBaGyEAOiEUp5ydozezb3qA3djLXbRbFScZlJUf7M-VDHFT1iiXgnNR8IsZL-PejZCy3NqkocztIYxJUrFsu7orZEFfHdCx34J5dD7-aQHezYCOIaUIg9Q2q2yDz1FZJ2si9wnKY4Jyn6A8JFjU4i_18YH_6d7POutLflv1EKIzMqvJhThE5bVNkv3b4g_7mLET |
| CitedBy_id | crossref_primary_10_3390_ijms26157032 crossref_primary_10_3390_nu17132189 crossref_primary_10_1371_journal_pone_0304176 crossref_primary_10_5501_wjv_v14_i2_106479 |
| Cites_doi | 10.1111/j.1365-2133.1996.tb03827.x 10.1111/bjd.14816 10.1111/j.2517-6161.1964.tb00553.x 10.4103/2277-9175.176368 10.1136/ard.54.11.886 10.1161/hc0902.104353 10.1515/cclm-2013-0502 10.1055/s-2007-1001672 10.1007/s00535-007-2060-x 10.1111/j.1365-2133.2005.06459.x 10.1093/clinchem/32.1.76 10.1164/ajrccm.159.3.9805060 10.1093/clinchem/36.2.265 10.1136/jim-2017-000609 |
| ContentType | Journal Article |
| Copyright | 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 |
| Copyright_xml | – notice: 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 |
| DBID | 0YH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 AABEP ADTPV AOWAS D8T D91 ZZAVC |
| DOI | 10.1080/00365513.2021.2001045 |
| DatabaseName | Taylor & Francis Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic SWEPUB Örebro universitet full text SwePub SwePub Articles SWEPUB Freely available online SWEPUB Örebro universitet SwePub Articles full text |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 0YH name: Taylor & Francis Open Access url: https://www.tandfonline.com sourceTypes: Publisher – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1502-7686 |
| EndPage | 652 |
| ExternalDocumentID | oai_DiVA_org_oru_95445 34779323 10_1080_00365513_2021_2001045 2001045 |
| Genre | Research Article Journal Article |
| GroupedDBID | --- -~X 00X 03L 0R~ 0YH 123 36B 4.4 5RE AAGDL AALUX AAMIU AAPUL AAQRR AAWTL ABBKH ABDBF ABEIZ ABJNI ABLIJ ABLJU ABLKL ABOCM ABUPF ABWVI ABXYU ACENM ACGEJ ACGFS ACIEZ ACUHS ADCVX ADRBQ ADXPE AECIN AENEX AEOZL AFKVX AFRVT AGDLA AGFJD AGRBW AGYJP AIJEM AIRBT AJWEG AKBVH ALMA_UNASSIGNED_HOLDINGS ALQZU ALYBC AMDAE AQTUD BABNJ BLEHA BOHLJ CCCUG COF CS3 DKSSO DU5 EAP EAS EBB EBC EBD EBS EBX EHN EMB EMK EMOBN EPL EPT ESX F5P H13 HZ~ KRBQP KSSTO KWAYT KYCEM L7B LJTGL M4Z O9- P2P Q~Q RNANH RVRKI SV3 TASJS TBQAZ TDBHL TERGH TFDNU TFL TFW TUROJ TUS UEQFS UHWXJ V1S WH7 ~1N .55 .GJ 34G 39C 3O- 53G 5VS AAJKZ AALIY AAORF AAPXX AAQQT AAYXX ABWCV ABZEW ACKZS ACOPL ACYZI ADFOM ADFZZ AEIIZ AFFNX AFLEI AJVHN AWYRJ BRMBE CAG CITATION CYYVM CZDIS DRXRE DWTOO EJD JENTW M44 NUSFT OVD QQXMO TEORI X7M ZGI ZXP ADYSH CGR CUY CVF ECM EIF NPM 7X8 AABEP ADTPV AOWAS D8T D91 ZZAVC |
| ID | FETCH-LOGICAL-c450t-ee32f877bb950cddcc5265b2bac44614d3ecede38f334ffbe221d55ee855a4243 |
| IEDL.DBID | 0YH |
| ISICitedReferencesCount | 5 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000718779700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0036-5513 1502-7686 |
| IngestDate | Tue Nov 04 16:40:08 EST 2025 Wed Oct 01 13:54:23 EDT 2025 Thu Apr 03 07:03:56 EDT 2025 Tue Nov 18 20:49:52 EST 2025 Sat Nov 29 02:41:44 EST 2025 Mon Oct 20 23:47:33 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Keywords | methotrexate reference ranges fibrosis Procollagen biomarker |
| Language | English |
| License | open-access: http://creativecommons.org/licenses/by/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c450t-ee32f877bb950cddcc5265b2bac44614d3ecede38f334ffbe221d55ee855a4243 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0001-8458-6448 0000-0002-4256-6008 0000-0002-0381-251X |
| OpenAccessLink | https://www.tandfonline.com/doi/abs/10.1080/00365513.2021.2001045 |
| PMID | 34779323 |
| PQID | 2597818453 |
| PQPubID | 23479 |
| PageCount | 4 |
| ParticipantIDs | proquest_miscellaneous_2597818453 crossref_citationtrail_10_1080_00365513_2021_2001045 crossref_primary_10_1080_00365513_2021_2001045 pubmed_primary_34779323 swepub_primary_oai_DiVA_org_oru_95445 informaworld_taylorfrancis_310_1080_00365513_2021_2001045 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-12-01 |
| PublicationDateYYYYMMDD | 2021-12-01 |
| PublicationDate_xml | – month: 12 year: 2021 text: 2021-12-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Scandinavian journal of clinical and laboratory investigation |
| PublicationTitleAlternate | Scand J Clin Lab Invest |
| PublicationYear | 2021 |
| Publisher | Taylor & Francis |
| Publisher_xml | – name: Taylor & Francis |
| References | e_1_3_3_7_1 e_1_3_3_6_1 e_1_3_3_8_1 e_1_3_3_17_1 e_1_3_3_14_1 e_1_3_3_16_1 e_1_3_3_15_1 e_1_3_3_3_1 Tukey JW. (e_1_3_3_9_1) 1977 e_1_3_3_10_1 e_1_3_3_2_1 e_1_3_3_5_1 e_1_3_3_12_1 e_1_3_3_4_1 e_1_3_3_11_1 Box GaC D. (e_1_3_3_13_1) 1964; 26 |
| References_xml | – ident: e_1_3_3_6_1 doi: 10.1111/j.1365-2133.1996.tb03827.x – ident: e_1_3_3_2_1 doi: 10.1111/bjd.14816 – volume: 26 start-page: 211 year: 1964 ident: e_1_3_3_13_1 article-title: An analysis of transformations publication-title: J R Stat Soc doi: 10.1111/j.2517-6161.1964.tb00553.x – ident: e_1_3_3_16_1 doi: 10.4103/2277-9175.176368 – ident: e_1_3_3_5_1 doi: 10.1136/ard.54.11.886 – ident: e_1_3_3_15_1 doi: 10.1161/hc0902.104353 – volume-title: Exploratory data analysis year: 1977 ident: e_1_3_3_9_1 – ident: e_1_3_3_10_1 – ident: e_1_3_3_8_1 doi: 10.1515/cclm-2013-0502 – ident: e_1_3_3_4_1 doi: 10.1055/s-2007-1001672 – ident: e_1_3_3_17_1 doi: 10.1007/s00535-007-2060-x – ident: e_1_3_3_7_1 doi: 10.1111/j.1365-2133.2005.06459.x – ident: e_1_3_3_11_1 doi: 10.1093/clinchem/32.1.76 – ident: e_1_3_3_3_1 doi: 10.1164/ajrccm.159.3.9805060 – ident: e_1_3_3_12_1 doi: 10.1093/clinchem/36.2.265 – ident: e_1_3_3_14_1 doi: 10.1136/jim-2017-000609 |
| SSID | ssj0003384 |
| Score | 2.3141887 |
| Snippet | The amino-terminal peptide of type III procollagen (PIIINP) is a byproduct of type III collagen synthesis that exhibits promise as a biomarker of fibrosis,... OBJECTIVE: The amino-terminal peptide of type III procollagen (PIIINP) is a byproduct of type III collagen synthesis that exhibits promise as a biomarker of... |
| SourceID | swepub proquest pubmed crossref informaworld |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 649 |
| SubjectTerms | Adult Aged Aged, 80 and over biomarker Biomarkers Collagen Type III Female fibrosis Humans Male methotrexate Middle Aged Peptide Fragments Procollagen reference ranges Reference Values Young Adult |
| Title | Reference interval for type III procollagen (PIIINP) using the Advia centaur PIIINP assay in adults and elderly |
| URI | https://www.tandfonline.com/doi/abs/10.1080/00365513.2021.2001045 https://www.ncbi.nlm.nih.gov/pubmed/34779323 https://www.proquest.com/docview/2597818453 https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-95445 |
| Volume | 81 |
| WOSCitedRecordID | wos000718779700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAWR databaseName: Taylor & Francis Journals Complete customDbUrl: eissn: 1502-7686 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0003384 issn: 0036-5513 databaseCode: TFW dateStart: 19490101 isFulltext: true titleUrlDefault: https://www.tandfonline.com providerName: Taylor & Francis |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LbxMxELagRYgLtDwDFLlSkeCwaOPHevcYAVEjQZRDW8LJ8rOKVCUom1Tqv2fG-4AiUA_0sJZ2vbZm7bE9nz37DSFHuZXBsVxlNgSbCS9dZkQUWcgNU6BSpkoEpmdf1HRazufVrPUmrFu3SsTQsSGKSHM1Dm5j684jDuOPFRiXBNAdSxAPIIW8S3YZQBP06sq_H_eTMSAw0fHuYpnuJ55_VXNtebpGXvo3E_QPftG0Jo0f3cLX7JGHrUFKR40G7ZM7YfmY3P_aHrk_IaueipYukn8kvAziUty7pZPJhOISiMoEmkjfzeDJdPaeojv9OQXjko785cJQ9AE12zVt8ilY7OYK6qOJ_qOmIDwNGC_84uopOR1_Pvl4nLVRGjInZL7JQuAslkpZW8ncee8cMu5bZo0DqDkUngcXfOBl5FzEaANjQy9lCKWURjDBn5Gd5WoZXhDKPKAdVnrPVAF1x8pIWVgVC1u4oir8gIiuc7RrKcwxksaFHv5iOk2NqbExdduYA_KhL_aj4fC4qUD1e8_rTdo8iU2kE81vKHvYqYmGkYrHL2YZVttaA9BUYB4JyQfkeaM_vThcKJgoGeS8bRSqz0H670-Ls5Ferc_h2uoK6ZNe_oeEr8gDvG18cl6Tnc16Gw7IPXe5WdTrN2n4QKrmJaQn428_ARE2FOo |
| linkProvider | Taylor & Francis |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LbxMxELagIODCm5KWh5FAoodFGz_Wu8eoEDUijXoIpTfLzypSlVR5VOq_74z3QYtAPcBhLzs71qw99szY428I-ZhbGRzLVWZDsJnw0mVGRJGF3DAFKmWqBGB6PFaTSXlyUl2_C4NplRhDxxooIq3VOLlxM7pNicMCZAUWJoHwjqUYD2IKeZfck2BrMa1vOvzZrcYQgokWeBd52ls8f2vmhn26gV76Jx_0N4DRZJSGT_7H7zwljxuXlA5qHXpG7oT5c_LgsDl0f0EWHRgtnaUMSfgY5KW4e0tHoxFFI4jqBLpIPx_Bm8nRHsWE-lMK7iUd-IuZoZgFajZLWtMp-OzmEtqjCQBkRUF6GrBi-NnlS_Jj-G26f5A1dRoyJ2S-zkLgLJZKWVvJ3HnvHGLuW2aNg2CzLzwPLvjAy8i5iNEGxvpeyhBKKY1ggr8iW_PFPLwmlHmId1jpPVMFtB0rI2VhVSxs4Yqq8D0i2tHRrgExx1oaZ7r_C-s0dabGztRNZ_bIl47tvEbxuI2huj70ep22T2Jd60TzW3g_tHqiYa7iAYyZh8VmpSHUVOAgCcl7ZLtWoE4cLhQslQwon2qN6igIAP51djzQi-UpPBtdIYDSzj9I-J48PJgejvV4NPm-Sx4hqc7QeUO21stNeEvuu4v1bLV8l-bSFQVgFxo |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagRRWX0vLqAgVXAgkOQVk_4uS4ol2xol3toZTeLD-rlardah-V-u-ZcR6lCNQDHHLJZKyJ89mesSffEPI-tzI4lqvMhmAz4aXLjIgiC7lhCiBlqkRgenasxuPy_LyaNNmEyyatEmPoWBNFpLkaB_eVj21GHNYfK7AuCUR3LIV4EFLIh2QzkWMBpE-HP7rJGCIw0fLuok77E8_fmrmzPN0hL_2TC_obv2hak4ZP_sPb7JDtxiGlgxpBu-RBmD0lWyfNkfszMu-oaOk05UfCw2Auxb1bOhqNKC6BCCZAIv04gTvjySeK6fQXFJxLOvDXU0MxB9SsF7SWU_DYzQ20RxP9x5KC8TRgvfDLm-fk-_Do9MvXrKnSkDkh81UWAmexVMraSubOe-eQcd8yaxyEmn3heXDBB15GzkWMNjDW91KGUEppBBP8BdmYzWdhj1DmIdphpfdMFdB2rIyUhVWxsIUrqsL3iGg_jnYNhTlW0rjU_Vum09SZGjtTN53ZI587tauaw-M-herXL69XafMk1pVONL9H96CFiYaRiscvZhbm66WGQFOBeyQk75GXNX46c7hQMFEykHyoAdVJkP77cHo20PPFBVxrXSF90qt_sPAd2ZocDvXxaPztNXmMkjo95w3ZWC3WYZ88cter6XLxNo2kn25SFb4 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reference+interval+for+type+III+procollagen+%28PIIINP%29+using+the+Advia+centaur+PIIINP+assay+in+adults+and+elderly&rft.jtitle=Scandinavian+journal+of+clinical+and+laboratory+investigation&rft.au=Pettersson-Pablo%2C+Paul&rft.au=Samyn%2C+Dieter&rft.au=Wasim%2C+Jamil&rft.au=Vink%2C+Martin&rft.date=2021-12-01&rft.issn=1502-7686&rft.eissn=1502-7686&rft.volume=81&rft.issue=8&rft.spage=649&rft_id=info:doi/10.1080%2F00365513.2021.2001045&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0036-5513&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0036-5513&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0036-5513&client=summon |